Read More Pharma Industry News Regeneron Pharmaceuticals (NASDAQ: REGN) bets on data scale as TriNetX deal opens access to 300 million patient records Regeneron is pairing with TriNetX to expand its health data reach and AI drug discovery ambitions. Read what the deal could change next. bySrinathApril 5, 2026